HNFl is a liver-specific transcription factor that plays the dominant role in determining the cell type-specific in vitro transcription of the albumin gene. Here we report the purification and preliminary characterization of HNFl. HNFl appears to be heavily glycosylated since it is retained on a wheat germ agglutinin-agarose column and can be eluted from it with N-acetylglucosamine, a property not observed with other factors binding to the albumin promoter. Using in vitro transcription assays we demonstrate that purified HNFl strongly stimulates albumin promoter activity in spleen nuclear extracts, which are devoid of this factor. Likewise, an artificial promoter consisting of two HNFl recognition sites in front of a TATA motif is strongly activated by HNFl in such extracts. In addition to stimulating transcription directly by binding to its cognate site, HNFl may further enhance albumin promoter activity by interacting cooperatively with other frans-acting factors.
Introduction
The developmental regulation of eukaryotic gene expression is controlled mostly at the level of transcription initiation. Three types of cis-acting sequences have been proposed to mediate the cell type-specific activation of genes. These include "chromatin openers:' transcriptional enhancers, and gene promoters (Serfling et al., 1985; Dy nan and Tjian, 1985; McKnight and Tjian, 1986; Grosveld et al., 1987) . While the mechanisms by which chromatin openers mediate unfolding of chromatin domains remain unknown, there is ample evidence that activation via enhancer and promoter elements is achieved by the interplay between &-acting DNA sequences and trans-acting proteins that recognize such DNA elements (Serfling et al., 1985; Dynan and Tjian, 1985; McKnight and Tjian, 1986; Maniatis et al., 1987; Ptashne, 1988) . The identification and functional characterization of DNA binding proteins involved in the transcriptional regulation of gene activity are therefore major research areas in developmental biology. The recent accomplishments in reproducing at least some aspects of tissue-and stage-specific transcription in cell-free systems (Gorski et al., 1986; MizushimaSugano and Roeder, 1986; Heberlein and Tjian, 1988; Biggin and Tjian, 1988) render the involved mechanisms amenable to experimental analysis.
To investigate the molecular basis for tissue-specific gene expression, we have chosen to study the promoter of the mouse albumin gene. This gene is strongly expressed only in liver cells. The minimal promoter sequences required for strong tissue-specific transcription have been defined by transient transfection experiments (Heard et al., 1987) and in vitro transcription in cell-free extracts derived from solid organs (Gorski et al., 1986) . The results obtained from both in vivo and in vitro studies are in excellent agreement and demonstrate that the promoter is contained within approximately 150 to 170 nucleotides of 5'-flanking sequence. As shown in Figure 1 , this region contains six closely spaced elements, named A to F, specifically recognized by nuclear factors (Lichtsteiner et al., 1987; C. Mueller and U. S., unpublished data: Wuarin et al., submitted) . In our in vitro transcription system this minimal promoter is about 50 times more active in liver nuclear extract (NE) than in spleen NE (Gorski et al., 1986; Maire et al., 1989) . Two strategies have been used to evaluate the relative contribution of each of the different binding sites: in vitro transcription of templates containing either promoters that had been mutated in the individual binding sites or artificial promoters that had been constructed by inserting oligomerized synthetic binding sites upstream of the TATA box (Maire et al., 1989; Westin et al., 1987) . Both approaches suggest that element B plays a key role in the strong, liver-specific transcription of the albumin promoter. First, substitution of this element decreased the transcriptional activity of the albumin promoter more than changes in any other element. Second, multimerization of element 6 yielded a strong and highly liver-specific artificial promoter. Moreover, similar sequence elements have been identified within the 5'-flanking regions of many other liver-specific genes (compiled in Courtois et al., 1988; Cereghini et al., 1988; Kugler et al., 1988) . For several of these elements, competition binding studies have been performed and suggest that these sequences indeed bind a common liver-specific factor, named hepatocyte nuclear factor 1 (HNFl) (Courtois et al., 1987) . The crucial role of HNFl in liver-specific gene expression is further suggested by a comparison of albumin promoters from various vertebrates. Besides the TATA motif, element 6, the cognate site for this factor, is the only wellconserved sequence element of the albumin promoters from Xenopus, chicken, mouse, rat, and man. For these reasons we have purified this important transcription factor and examined its biochemical properties as well as its ability to activate transcription in an in vitro complementation assay.
Results

HNFl Is a Glycosylated
Liver-Specific Transcription Factor To examine the tissue distribution of HNFl, NEs were prepared from liver, brain, spleen, and thymus. Equal amounts of protein from the different NEs were incubated The transcription factors occupying these elements have been identified and are schematically listed. The parentheses for C/EBP indicate that this factor binds to sites A and F with low affinity.
with a synthetic DNA probe containing site B, and the DNA-protein complexes were resolved from free DNA by gel electrophoresis (Figure 2) . A strong and specific complex with site B is only observed with liver NE, although some additional, less abundant, complexes were also detected in NEs from other tissues. Competition experiments suggest that all of these weaker complexes are due to nonspecific DNA binding proteins (data not shown).
Recently, Jackson and Tjian (1988) have shown that several RNA polymerase II transcription factors are glycosylated. In the case of the transcription factor Spl they have demonstrated the presence of approximately eight N-acetylglucosamine residues covalently attached to the protein. This type of sugar residue is avidly bound by the lectin wheat germ agglutinin (WGA) (Nagata and Burger, 1974) . We examined whether HNFl is posttranslationally modified in the same way. Total liver NE was loaded on a WGA-agarose column, and proteins were eluted with 0.3 M N-acetylglucosamine.
As shown in Figure 3 , a large proportion of HNFl is retained on the lectin column and is competed off the resin by 0.3 M N-acetylglucosamine. This indicates that a significant fraction of the liverspecific HNFl, like Spl, contains N-acetylglucosamine residues (Jackson and Tjian, 1989) . In contrast, the proteins giving rise to the faster-migrating complexes are not bound by the lectin-agarose.
Likewise, none of the other factors recognizing albumin promoter elements (CIEBP, DBP, NF-Y, NFl-like factors) appear to be sufficiently glycosylated to be retained on the lectin column (data not shown).
During the purification of HNFl, we followed its DNA binding activity by the gel retardation assay described above. Liver NE was first fractionated by chromatography on a heparin agarose-column, from which the HNFl activity elutes at 0.3 M KCI. Since this salt concentration does not impede the interaction between the lectin and the sugar residues, this fraction was directly applied to the WGA-agarose matrix. HNFl was detached from the lectin column with 0.3 M N-acetylglucosamine and further purified close to homogeneity by DNA affinity chromatogra- phy (Kadonaga and Tjian, 1986) . The HNFl activity was eluted from this column at 0.5 M KCI. A silver-stained protein gel of the active fractions from the heparin-agarose and the WGA-agarose columns as well as all the fractions from the DNA affinity column is shown in Figure 4A . In the sugar eluate from the lectin column, HNFl is already visible as a band corresponding to a size of about 80 kd. This protein is differentially re- Four milliliters of liver NE (4-5 mglml) was chromatographed on a WGA-agarose column (2 ml packed bead volume) at a flow rate of 10 mllhr, and 4 ml fractions were taken. Elution was performed in the presence of 0.3 M N-acetylglucosamine.
Equivalent volumes of each fractions (1 $) were incubated with an albumin site B probe. The samples were loaded on a 6% nondenaturing polyacrylamide gel. tained on the 6 element DNA column and elutes from it in several 0.5 M KCI fractions and to a minor extent in the 0.6 M KCI fraction (as judged from. the gel retardation assay). As seen in the gradient gel described in Figure 4B , the final HNFl preparation consists of one major polypeptide with an apparent size of about 80 kd.
The purified protein interacts strongly and specifically with its binding site as shown by the DNAase I protection experiment of Figure 4C . The observation that the final protein preparation contains only one major protein species suggests that HNFI binds either as a monomer or a homopolymer. On the basis of gel retardation assays performed with a large excess of DNA probe (31 bp, corresponding to a MW of 20,000), we estimate that HNFl constitutes about 0.03% of liver nuclear proteins if HNFl binds as a monomer (80 kd) or 0.06% if it binds as a homodimer (160 kd). Since we extract about 5 pg of nonhistone proteins per diploid cell nucleus (5 pg of DNA), the percentages given above correspond to about 11,000 and 22,000 molecules, respectively, of DNA binding HNFl per diploid cell nucleus. Our three-step purification protocol yields about 30 ng of HNFl per mg of nuclear proteins, corresponding to a recovery of about 15% (see legend to Figure 4A ).
Purified HNFl Activates Transcription by Binding to Its Cognate Site B While the experiments
shown in the previous section demonstrate the ability of the purified protein to recognize its target sequence, they do not address its putative quality as a transcriptional activator. Since HNFl activity appears to be restricted to liver, functional analysis of HNFl is greatly facilitated by the availability of transcriptionally competent NEs from other tissues, such as spleen, that are devoid of this factor. The two templates shown in Figure 5C were used to examine the ability of HNFl to act as a Pans-activator. The test gene (wt) generates a transcript of 230 nucleotides and contains the wild-type promoter (with a functional HNFl element). The control gene (MutB) generates a transcript of 400 nucleotides and bears a mutated promoter incapable of binding HNFl. In this promoter the core of the HNFl binding site had been substituted for by 11 nucleotides of an unrelated sequence (Maire et al., 1989) . The control and test genes were mixed and transcribed in spleen NE supplemented with the different fractions from the DNA affinity column.
As shown in Figure 58 , both templates yield a similarly low amount of in vitro transcripts in reactions supplemented with column fractions devoid of HNFl DNA binding activity (FT and fractions eluting at 0.2 M and 0.3 M KCI). In contrast, the in vitro transcription efficiency of the test gene is greatly augmented by addition of the 0.5 M KCI fraction, which contains the bulk of purified HNFl, and is weakly enhanced by the 0.6 M KCI fraction, which contains a smaller amount of HNFl. Since the transcriptional efficiency of the control gene remains unaffected by the addition of HNFl, we conclude that this factor stimulates the transcriptional initiation frequency by specifically binding to its cognate site.
Two and F. To demonstrate autonomous activation of transcription by HNFI, we used a synthetic promoter consisting of two B elements in addition to a TATA box. As shown in Figure  6 , this promoter is strongly activated in spleen NE by purified HNFl. In this experiment an adenovirus major late promoter-containing template was used as an internal control. This promoter is similarly active in liver and spleen NEs (Gorski et al., 1966; Maire et al., 1969) but is inert to complementation with purified HNFl, while the synthetic promoter containing the HNFl binding sites is
Cooperative
Interactions of HNFl with Other Factors Binding to the Albumin Promoter The HNFl recognition site within the albumin promoter contains the sequence GATC, which can be methylated in dam+ bacterial strains. When this site is methylated, its affinity for purified HNFl is reduced at least 30-fold (Figure 78) as measured by gel retardation. Surprisingly, this modification lowers the transcriptional efficiency of the albumin promoter much less dramatically (less than 2-fold; The methylated state of plasmids grown in either dam-or dam+ strains was examined by digestion of the DNAs with SauSA, which cleaves at both methylated and unmethylated GATC sequences, and with Mbol, which can only cleave at unmethylated GATC sequences.
"Unmethyl" and "methyl" refer to plasmids propagated in dam-and dam+ bacterial strains, respectively (see Experimental Procedures). (B) Gel retardation assays performed with purified HNFI and promoter fragments (-170 to -23) isolated from the two plasmids Alb400/-170 and Alb400/-170 Bx68 propagated in either dam-(-) or dam+ (+) bacteria see Figure 8 , Alb400/-170) than complete elimination of the HNFl site (at least lo-fold). This result may be interpreted in two different ways. Either the HNFl concentration in the in vitro transcription reaction is sufficiently high to assure occupancy of the methylated, low-affinity site, or the filling of this weak site is facilitated by cooperative interactions with factors bound to other c&acting elements. In the first instance, the relative effect of methylation should be similar with promoters containing all &-acting elements and promoters bearing only the HNFl site. In the second case, methylation is expected to produce a much more dramatic effect in truncated promoters devoid of the cis-acting elements that may be required for cooperative interactions between different factors.
To discriminate between the two possibilities, we compared the transcription efficiency of methylated (dam+) and unmethylated (dam-) albumin promoters that contain either all cis-acting elements (Alb400/-170) or only elements A and B (Alb400/-74).
Since the template plasmids contains many additional Dam target sites, we examined whether these additional methylated sites also interfere with transcription.
This was achieved by replacing the mouse albumin HNFl site by the functional Xenopus albumin HNFl site (Schorpp et al., 1988a ; Figure 8 , Alb400/-170 Bx68). This latter binding site has, at the 3' boundary, a Dam methylation sequence that does not negatively interfere with HNFl binding (Figures 7A and  78) . Figure 8 shows the in vitro transcription in liver NEs of the various templates propagated in either dam+ or dam-E. coli strains. The data of several independent experiments are given in the legend of Figure 8 . The Alb400/-170 Bx68 template, which is devoid of an interfering Dam methylation sequence (GATC) within its HNFl binding site, shows an approximately e-fold decrease in transcription when methylated, suggesting that methylations outside the HNFl binding site may affect transcription to some extent. A similarly small decrease in transcription efficiency is also observed with the template carrying the entire mouse albumin promoter. Thus in the context of a complete promoter (Alb400/-170), methylation of the HNFl binding site causes only a marginal reduction in transcription whereas its elimination (substitution with unrelated DNA) results in a lo-fold decrease in transcription. In contrast to the results obtained with the entire promoter (Alb400/-170), transcription of the truncated promoter (Alb400/-74) is lowered at least lo-fold when it is methylated (compare Alb400/-74 lanes in Figure 8) , similar to the level of transcription of an equivalent construct eliminating the HNFl site (see Figure 8 , Alb400/-58).
Taken together, these data strongly suggest that cooperative interactions involving HNFl and other factors binding to upstream albumin promoter elements may occur. Experiments with other purified factors will be required to identify the components and the mechanisms responsible for the synergistic activation suggested by our experiments.
Functional
HNFl Sites Are Conserved during Evolution Sequence comparisons of albumin promoters from the vertebrates Xenopus, chicken, mouse, rat, and man Transcription reactions were performed in liver NE as described before. In each case an internal control (AdML190) was used to calibrate the efficiency of transcription.
The control template gives rise to a transcript of 190 nucleotides (ML). The albumin constructs are described in the legend to Figure 7 , except for Alb400/-74 and Alb400/-58, which contain 74 bp and 58 bp. respectively, of upstream albumin promoter sequences (Gorski et al., 1986) . All of the albumin promoter-containing plasmids were grown in dem+ (JMlOl) or darn-(&37) E. coli, and generate a transcript of 400 nucleotides (Alb). The regions containing the two radiolabeled transcripts were excised from dried gels and counted in Aquasol (Amenham) in a liquid scintillation counter. The transcription signals thusobtained were corrected for errors in sample handling by assuming that transcription for the plasmid AdMU was equally efficient in all reactions, The value for Alb400/-170 dam-was arbitrarily set to 100%. The relative transcription values of the other templates are as follows: Alb400/-170 dam+ (41%) Alb400/-74 dam-(19%) Alb400/-74 dam+ (2%) Alb400/-58 dam-(4%) Alb400/-58 dam+ (4%) Alb400/-170 6x68 dam-(96%) and Alb400/-170 Bx68 dam+ (54%). (Schorpp et al., 1988b; Heard et al., 1987) indicate that the HNFl binding site and the TATA box are the only conserved promoter motifs present in all of these species. Gel retardation experiments presented in Figure 78 and DNAase I protection studies (S. L., unpublished data) show that the Xenopus albumin HNFl element is recognized by purified rat HNFl. Furthermore, the template bearing the hybrid promoter (Alb400/-170 Bx68) transcribes nearly as well as the one carrying the wild-type mouse promoter (Alb400/-170 dam-) (Figure 8 ). Thus the Xenopus site is able to functionally replace its mouse homolog.
Discussion
We have taken advantage of a tissue-specific in vitro transcription system developed in our laboratory (Gorski et al., 1986; Lichtsteiner et al., 1987; Maire et al., 1989) to study the importance of diffusible transcription factors for the liver-specific activity of the mouse albumin promoter. The observation that in this system reporter genes fused to the albumin promoter are preferentially transcribed in liver NEs compared with NEs from other sources suggests the hypothesis that factors whose activity is restricted to hepatocytes are likely to be involved in the liver-specific in vitro transcription of the albumin gene. We (Lichtsteiner et al., 1987) and others (Babiss et al., 1987; Cereghini et al., 1987) have therefore attempted to establish an inventory of the DNA binding proteins recognizing albumin promoter elements. All of these studies have revealed multiple binding sites for specific proteins within the minimal essential promoter of the albumin gene (Gorski et al., 1986; Heard et al.,' 1987) . Identification of the proteins binding to these sites has revealed one factor that is liver specific (HNFl; Courtois et al., 1987; Kugler et al., 1988; Monaci et al., 1988) factors that are enriched in hepatocytes (CIEBP and NFl-related proteins; Johnson et al., 1987; Lichtsteiner et al., 1987) , and a CCAAT binding factor that is present at similar levels in all investigated tissues (NF-Y, Dorn et al., 1987; Lichtsteiner et al., 1987; Chodosh et al., 1988; Hatamochi et al., 1988) .
Here we report the purification and preliminary characterization of HNFl, which binds to proximal albumin promoter element B. For the following reasons we believe that this is a crucial regulatory molecule governing liverspecific gene expression. First, among the identified DNA binding proteins HNFl is the most liver specific (Figure 2 ; Courtois et al., 1987; Kugler et al., 1988; Cereghini et al., 1988) . Second, destruction of its cognate site in the albumin promoter results in a lo-fold decrease in transcriptional activity in a liver NE. This is the most dramatic effect of any of the mutations affecting a single binding site upstream of the TATA motif (Maire et al., 1989) . Third, a synthetic promoter composed of multimerized 6 elements (HNFl binding sites) and a TATA box is strongly active in liver NE and inactive in spleen NE (Maire et al., 1989) . Fourth, specific binding sites for HNFl have been found in many additional liver-specific promoters (a,-antitrypsin, a-and b-fibrinogen, transthyretin, and a-fetoprotein). Fifth, the HNFl recognition site is the sole albumin promoter element, in addition to the TATA box, that has been conserved from Xenopus to man.
The purification of HNFl has been greatly aided by its high level of glycosylation. By taking advantage of this property in one step of the purification process, three successive chromatographic fractionations (heparin-agarose, lectin [WGA]-agarose, and DNA affinity) resulted in a very pure preparation of HNFl. The purified protein migrates as a single band corresponding to about 80 kd on SDS-polyacrylamide gels. The size of our purified protein is in reasonable agreement with that estimated by others on the basis of cross-linking experiments (Courtois et al., 1988; Cereghini et al., 1988) and purification (Courtois et al., 1988) .
To test the ability of HNFl to act as a trans-activator, an HNFl-dependent in vitro transcription assay was developed. It consists of the complementation of a NE extract from spleen with purified factor. The spleen does not express the albumin gene and does not contain detectable amounts of HNFl activity. We show here that addition of purified HNFl to a spleen NE results in a strong activation of either an albumin promoter containing a functional B site or a synthetic promoter consisting of two tandemly repeated B elements and a TATA motif. We are aware of only two other tissue-specific transcription factors of mammalian origin that have been shown to activate in vitro transcription in reconstituted systems: GHFIIPit-1, a pituitary-specific protein, activates in vitro transcription of growth hormone and prolactin genes when added to HeLa extracts (Bodner and Karin, 1987; Nelson et al., 1988) , and OTF-2, a B cell-specific factor, enhances in vitro transcription from immunoglobulin promoters in OTF-2-depleted B cell extracts (Scheidereit et al., 1987; LeBowitz et al., 1988) .
In addition to activating transcription autonomously by filling its cognate site on the albumin promoter, HNFl may be involved in cooperative interactions with other factors. This is suggested by comparison of the in vitro transcription efficiencies obtained with templates containing either the wild-type promoter or a series of mutated promoters. Substitution of the HNFl binding site has a much more dramatic effect on in vitro transcription than its methylation, as long as other upstream sequences (up to -170) are present. Perhaps the binding of the tissue-specific factor HNFl to its cognate site facilitates the binding of more general factors occupying elements within the albumin promoter, thereby increasing their activation potential in a liver-specific fashion.
We have shown that the HNFl recognition element within the albumin promoter has been functionally conserved during vertebrate evolution. Thus, purified rat HNFl binds specifically to the homologous sequence of the Xenopus albumin promoter. Furthermore, in an in vitro transcription assay this Xenopus DNA element can functionally substitute for the authentic mouse sequence. Other workers have recently reported related data (Schorpp et al., 1988b; Ryffel et al., 1989) . Using gel retardation assays with crude rat liver NE, they also detect a rat protein specifically recognizing the Xenopus sequence. Deletion and substitution of this element are the only mutations upstream of the TATA motif that affect transcription from the Xenopus albumin promoter in mouse or rat expression systems.
Interestingly, a dedifferentiated hepatoma cell line incapable of expressing albumin has been found to be devoid of the normal HNFl protein (Baumhueter et al., 1988; Cereghini et al., 1988) . Instead, this cell line contains a smaller protein (70 kd) recognizing HNFl target sequences (Baumhueter et al., 1988) . This binding activity has therefore been termed variant HNF (vHNF). While the structural relationship between these two proteins remains to be elucidated, it is tempting to speculate that vHNF is a nonglycosylated form of HNFl. Perhaps the dedifferentiated hepatoma cells have lost the ability to glycosylate HNFl correctly. If glycosylation of HNFl is important for its ability to activate transcription, as has been suggested for Spl (Jackson and Tjian, 1988) , a defect in HNFl glycosylation could explain the inactivity of the albumin gene in dedifferentiated hepatoma cells. Such a defect would also explain why these two proteins do not coexist within a given cell line (Baumhueter et al., 1988; Cereghini et al., 1988) .
A number of different regulatory mechanisms could account for the liver specificity of HNFl. Recently, recombinant cDNAs for two other tissue-specific factors, OTF-2 and GHFIIPit-1, have been isolated and used as probes for the corresponding mRNAs in Norhtern blot analyses of RNA from various tissues (Scheiderheit et al., 1988; Miiller et al., 1988; Bodner et al., 1988) . In both cases the respective mRNAs are restricted to the cell types expressing the target genes for these two factors. However, NF-KB, a factor activating the enhancer of kappa immunoglobulin light chain genes specifically in B cells, appears to be present in a repressed form in many different cells (Baeuerle and Baltimore, 1988a) . Activation of NF-KB appears to involve dissociation from a cytoplasmic inhibitor, IKB (Baeuerle and Baltimore, 1988b) . All of our attempts to recruit HNFl activity from whole-cell, nuclear, or cytoplasmic extracts from two nonliver tissues (spleen, thymus) have thus far failed (S. L., J6r6me Wuarin, and U. S., unpublished data). These negative results would be compatible with a model in which the liver-specific production of HNFl is regulated on the level of its mRNA. Clearly, the final resolution of this problem awaits cloning of the HNFl gene. The purification of HNFl is an important step toward this goal.
Experimental Procedures
Gel Retardation Assays These assays are derived from the original protocols described by Garner and Revzin (1981) and by Fried and Crothers (1981) . The wild-type and mutated albumin promoter fragments (-170 to -23; see LichtSteiner et al., 1987) were end labeled with Klenow enzyme and used as probes in binding reactions (experiments of Figure 78 ). Doublestranded oligonucleotides containing site B of the albumin promoter were obtained by annealing the complementary sequences 5'-CTG-CACAGTTATTGGTTAAAGAAGTA-3' and 5'~TGCAGTACTTCTTTAACC-AATAACTG3' and were labeled with Klenow enzyme (experiments of Figures 2,3, and 5 ). Approximately 1 ng samples of these DNAs were incubated with various amounts of proteins in a 20 pl reaction containing 1 bg of poly(dl-dC) as described in Lichtsteiner et al., (1987) . The gels were run in 0.25x TBE buffer at 150 V for 2 hr at 4%.
DNAase I Footprinting
The plasmid Alb400/-170 was labeled at the EcoRl site (close to position -170) with Klenow enzyme and cleaved with Hindlll, and the resulting fragment was isolated on a 1% low-gelling-temperature agarose gel (Sigma). The 600 bp DNA fragment thus obtained was used as a probe for DNAase I footprint analysis as described in LichtSteiner et al. (1987) .
Nuclear Extract
Preparation Liver NEs were prepared as described in Lichtsteiner et al. (1987) . Spleen NEs were prepared according to Gorski et al. (1986) and Maire et al. (1989) in a modified homogenization buffer to minimize proteolytic degradation.
The tissue was homogenized, until most of the cells were broken, in the following solution: 1% (w/v) low-fat milk, 2.2 M sucrose, 10 mM HEPES (pH 7.6) 25 mM KCI, 0.15 mM spermine, 0.5 mM spermidine.
1 mM EDTA, 10% glycerol, 1 mM DTT, 0.1 mM PMSF, 1 ugglml leupeptin, 1 uglml pepstatin A, and 0.1 mM benzamidine. The cushions were prepared as described without addition of low-fat milk to the solution.
Transcriptional
Activation The procedure was adapted from Gorski et al. (1986) : 800 ng of mixed DNA templates (400 ng of each) was preincubated for 5 min on ice with 7 ul of the various dialyzed fractions obtained after DNA affinity chromatography.
Then 6 ul of spleen NE (8.5 mglml) was added in a final reaction of 20 ul containing 25 mM HEPES (pH 7.6), 50 mM KCI, 6 mM MgClz, 0.6 mM each of ATP and CTP, 35 uM UTP 7 uCi of [3zP]UTP, 0.1 mM 3'-0-methyl-GTP, 12% glycerol, and 30 U of RNasin. The transcription reactions were performed for 45 min at 30%. The reactions were then stopped by the addition of 380 ul of stop solution (1% SDS, 20 mM Tris-HCI [pH 7.51, 5 mM EDTA, 250 mM NaCI, and 50 uglml tRNA). Proteinase K was added to a final concentration of 100 uglml, and the samples were digested for 15 min at 37%. The samples were chloropane extracted; the RNA was precipitated and resuspended in formamide dyes, boiled for 2 min, and loaded on a 4% sequencing gel. The bromophenol blue was allowed to run to the middle of the gel. The gels were fixed, dried, and exposed with a Lightening Plus intensifier screen.
HNFl Purification Liver NE (240 mg) was loaded on a 30 ml heparin-agarose (IBF) column. The proteins were step eluted with CS (12.5 mM HEPES jpH 7.61, 10% glycerol, 1 mM EDTA, 5 mM MgClz, 5 mM DTT, 0.1% Trasylol, and 0.01% N,N-dimethyldodecylamine-N-oxide) containing increasing amounts of KCI. HNFI eluted at 0.3 M KCI and was directly loaded on a 2 ml preequilibrated WGA-agarose column (Sigma). The column was extensively washed with CB containing 0.1 M KCI before the bound material was eluted with the same buffer containing 0.3 M N-acetylglucosamine.
The WGA-agarose eluate was mixed with poly (dl-dC) at a final concentration of 4 ugglml and left 30 min on ice before loading on the specific DNA column, The affinity column was prepared by cross-linking multimerized site B DNA to CNBr-activated Sepharose 48 (Pharmacia) according to Kadonaga and Tjian (1986) . The eluate was loaded on a 2 ml affinity column (40 uglml of DNA), and the flowthrough was reloaded twice on the column before elution was started. Elution was done as indicated in the legend to Figure 4 . The fractions from all the purification steps were tested by the gel retardation assay.
The WGA-agarose columns were regenerated by washing successively with IO column volumes of 0.1 M Tris-HCI, 0.5 M NaCl (pH 8.5) and 10 column volumes of 0.1 M sodium acetate, 0.5 M NaCl (pH 4.5) and reequilibrating in starting buffer,
Other Techniques
Plasmids were obtained by a modification of the alkaline lysis procedure described previously (Gorski et al., 1986) . End labeling by filling in 5'protruding ends with Klenow enzyme and [a-3zP]dNTPs was carried out according to Maniatis et al. (1982) . SDS-polyacrylamide gels were run according to Laemmli (1970) . Site-directed mutagenesis was performed as described in Lichtsteiner et al. (1987) . Plasmids were propagated in either E. coli JMlOl (dam+) or 8237 (dam-).
